ASX Share rice
Tue 18 May 2021 - 11:11:am (Sydney)

UCM Share Price

USCOM LIMITEDUCMHealth Care Equipment & Services

UCM Company Information

Name:

Uscom Limited

Sector:

Healthcare

Industry:

Medical Devices

GIC Industry:

Health Care Equipment & Supplies

GIC Sub Industry:

Health Care Equipment

Address:

66 Clarence Street Sydney NSW Australia 2000

Phone:

61 2 9247 4144

Founder, Exec. Chairman, CEO & Chief Scientist:

Dr. Robert Allan Phillips DMU, Ph.D.(Med), AMS, MPhil (Med), FASE, FIR

Company Sec. & Non-Exec. Director:

Mr. Brett Crowley B.Com., C.A., BCom, DipLaw, CA

Gen. Mang.:

Mr. Nicholas Schicht

Company Overview:

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function using Doppler ultrasound; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm; and SpiroSonic, a pulmonary function testing device based on multi-path ultrasound technology. The company provides Ventitest, a ventilator testing device; Ventitest sensor to test lung function; and The SpiroSonic AIR, a digital home care spirometer which feeds digital lung function signals through a phone app. It serves hospitals and other medical care locations through a network of distribution partners. The company was incorporated in 1999 and is headquartered in Sydney, Australia.

UCM Share Price Information

Shares Issued:

153.95M

Market Capitalisation:

$20.78M

Revenue (TTM):

$6.06M

Revenue Per Share (TTM):

$0.04

Earnings per Share:

$-0.01

Profit Margin:

-0.0173

Operating Margin (TTM):

$0.04

Return On Assets (TTM):

$0.03

Return On Equity (TTM):

$-0.03

Quarterly Revenue Growth (YOY):

1.84

Gross Profit(TTM):

$3.85M

Diluted Earnings Per Share (TTM):

$-0.001

UCM CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-38,159

Change To Liabilities:

$-16,408

Total Cashflow From Investing Activities:

$-38,159

Net Income:

$-1,331,335

Total Cash From Operating Activities:

$-283,225

Depreciation:

$565.38K

Change To Inventory:

$-313,692

Change To Account Receivables:

$311.55K

Sale Purchase Of Stock:

$750K

Capital Expenditures:

$15.75K

UCM Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-1,314,190

Net Income:

$-1,331,340

Gross Profit:

$3.56M

Operating Income:

$-1,510,830

Interest Expense:

$89.90K

Income Tax Expense:

$17.15K

Total Revenue:

$4M

Cost Of Revenue:

$435.01K

UCM Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$498.12K

Total Liabilities:

$2.50M

Total Stockholder Equity:

$3.42M

Other Current Liabilities:

$147.75K

Total Assets:

$5.92M

Common Stock:

$34.20M

Retained Earnings:

$-34,016,125

Other Liabilities:

$66.70K

Other Assets:

$83.46K

Cash:

$1.92M

Total Current Liabilities:

$1M

Property - Plant & Equipment:

$1.65M

Net Tangible Assets:

$2.92M

Total Current Assets:

$3.68M

Net Receivables:

$820.84K

Short-Term Investments:

$2.24M

Inventory:

$828.85K

Accounts Payable:

$269.89K

Non Currrent Assets (Other):

$83.46K

Short-Term Investments:

$2.24

Non Current Liabilities Total:

$1.50M

UCM Share Price History

UCM News

30 Nov, 2020
It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...
31 May, 2020
Whilst it may not be a huge deal, we thought it was good to see that Xianhui Meng, who is a company insider, recently...